Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

OLFEN 11,6 MG/G GEL - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/OLFEN 11,6 MG/G GEL

Approved

STANDARD

OLFEN 11,6 MG/G GEL

Teva B.V.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Mar 21, 2022
Approval ID: 0d08116c9cc4eafb
Company: Teva B.V.
Type: Standard

Approval Details

Approval Id: 0d08116c9cc4eafb
Drug Cima Aemps Name: OLFEN 11,6 MG/G GEL
Register Number: 86651
Holder Company Name: Teva B.V.
Marketing Company Name: Teva Pharma S.L.U.
Holder Company Detail Path: /organization/teva-pharma-b-v
Authorization Date: 2022-03-21
Dosage Form: GEL
Dose: 11,6 mg/g
Route Of Administration: USO CUTÁNEO
Prescription Type: Sin Receta
Commercialized: Yes
Company Name: Teva B.V.
Company Detail Path: /organization/teva-pharma-b-v

Company Information

Pharmaceutical Company Name: Teva Pharma B.V.
Country Name: Netherlands
City Name: haarlem,noord-holland,country_nl
Address: Swensweg 5
Website: http://www.tevapharm.com

Active Ingredients

DICLOFENACO DIETILAMINA

11,6 mg/g

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Mar 21, 2022

Approval ID

0d08116c9cc4eafb

Type

Standard

Back to CIMA-AEMPS Approvals